Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
T-cell acute lymphoblastic leukemia
Biotech
Volatile day for CAR-T biotechs after FDA reveals safety review
CAR-T therapy biotechs had a tough day at the market after the FDA announced a probe into secondary cancers that can occur after the treatments.
Annalee Armstrong
Nov 28, 2023 4:35pm
Experimental breast cancer drug could target leukemia, too
Jul 23, 2018 11:00am
In recovery mode, Threshold gets hoped-for licensing deal
Jun 1, 2017 7:14am
